Skip to main content

Table 3 Multivariate analyses of risk factors for 30-day mortality in patients with CRE BSI

From: Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae in hematological patients: assessment of risk factors for mortality and treatment options

Risk factor

Multivariate analysis

OR (95% CI)

P value

Underlying hematological disease

0.337 (0.048–2.367)

0.274

Length of neutropenia (≥ 14 days)

3.731 (0.355-40)

0.272

Pitt bacteremia score (≥ 2)

4.464 (0.902–22.222)

0.067

Septic shock

10.526 (1.376–76.923)

0.023

Pulmonary infection

6.289 (1.351–29.412)

0.019

Appropriate therapy started within 24 h

0.288 (0.066–1.255)

0.097

CAZ-AVI-containing regimen

0.068 (0.007–0.651)

0.020

  1. OR, odds ratio; CI, confidence interval; CAZ-AVI, ceftazidime-avibactam